Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
ATX code V03AB32 Indications for use prevention of neurotoxicity during chemotherapy with cisplatin or other related compounds List of information required before use Contraindications hypersensitivity to the active substances or to any of the excipients Necessary precautions for use In case of adverse reactions during intravenous administration, use of the drug should be discontinued immediately
Unlike other current weight loss medications on the market, it simultaneously activates three key hormone receptors: GLP-1 receptor GIP receptor Glucagon receptor By targeting all three, Retatrutide delivers a comprehensive approach to weight management by: Suppressing appetite and slowing digestion Enhancing metabolic activity Regulating blood sugar levels Promoting fat breakdown In comparison to other weight loss drugs like Wegovy and Ozempic ( Semaglutide ) THAT only target GLP-1, while other options like Zepbound and Mounjaro ( Tirzepatide ) activate both GLP-1 and GIP
Phase 2 T2D topline March 2026: up to 2.16% HbA1c reduction at 24 weeks
Retrieved from Ghusn, W., Hurtado, M
US$ 29.01
US$ 23.92
US$ 27.26
US$ 29.37
